512 related articles for article (PubMed ID: 10751037)
21. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
Dahan A; Sabit H; Amidon GL
AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the transport of the organic cation [3H]MPP+ in human intestinal epithelial (Caco-2) cells.
Martel F; Calhau C; Azevedo I
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):505-13. PubMed ID: 10832604
[TBL] [Abstract][Full Text] [Related]
23. Transport characteristics of ebastine and its metabolites across human intestinal epithelial Caco-2 cell monolayers.
Imamura Y; Shimizu K; Yamashita F; Yamaoka K; Takakura Y; Hashida M
Biol Pharm Bull; 2001 Aug; 24(8):930-4. PubMed ID: 11510488
[TBL] [Abstract][Full Text] [Related]
24. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.
Ushigome F; Takanaga H; Matsuo H; Yanai S; Tsukimori K; Nakano H; Uchiumi T; Nakamura T; Kuwano M; Ohtani H; Sawada Y
Eur J Pharmacol; 2000 Nov; 408(1):1-10. PubMed ID: 11070177
[TBL] [Abstract][Full Text] [Related]
25. Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells.
Yamamoto W; Verweij J; de Bruijn P; de Jonge MJ; Takano H; Nishiyama M; Kurihara M; Sparreboom A
Anticancer Drugs; 2001 Jun; 12(5):419-32. PubMed ID: 11395570
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
27. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
28. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.
Hunter J; Hirst BH; Simmons NL
Pharm Res; 1993 May; 10(5):743-9. PubMed ID: 8100632
[TBL] [Abstract][Full Text] [Related]
29. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
Hu M; Chen J
Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
[TBL] [Abstract][Full Text] [Related]
30. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
Bourdet DL; Thakker DR
Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
[TBL] [Abstract][Full Text] [Related]
31. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
[TBL] [Abstract][Full Text] [Related]
32. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators.
Hunter J; Jepson MA; Tsuruo T; Simmons NL; Hirst BH
J Biol Chem; 1993 Jul; 268(20):14991-7. PubMed ID: 8100817
[TBL] [Abstract][Full Text] [Related]
33. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
Augustijns PF; Bradshaw TP; Gan LS; Hendren RW; Thakker DR
Biochem Biophys Res Commun; 1993 Dec; 197(2):360-5. PubMed ID: 7903526
[TBL] [Abstract][Full Text] [Related]
35. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
36. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
[TBL] [Abstract][Full Text] [Related]
37. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.
Wils P; Phung-Ba V; Warnery A; Lechardeur D; Raeissi S; Hidalgo IJ; Scherman D
Biochem Pharmacol; 1994 Oct; 48(7):1528-30. PubMed ID: 7945455
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of monocarboxylic acid, large neutral amino acid, bile acid and peptide transporters, and P-glycoprotein in MDCK and Caco-2 cells.
Putnam WS; Ramanathan S; Pan L; Takahashi LH; Benet LZ
J Pharm Sci; 2002 Dec; 91(12):2622-35. PubMed ID: 12434407
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics of atorvastatin.
Lennernäs H
Clin Pharmacokinet; 2003; 42(13):1141-60. PubMed ID: 14531725
[TBL] [Abstract][Full Text] [Related]
40. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
